Efferon CT Hemoadsorption for Cardiogenic Shock in Acute Myocardial Infarction

NARecruitingINTERVENTIONAL
Enrollment

60

Participants

Timeline

Start Date

April 29, 2025

Primary Completion Date

April 29, 2027

Study Completion Date

July 31, 2027

Conditions
Myocardial InfarctionCardiogenic Shock
Interventions
DEVICE

Efferon CT

"Efferon CT (JSC Efferon, Moscow, RF) is a device for extracorporeal blood purification by direct hemoadsorption. Detoxification is carried out by sorption of cytokines and other products of endogenous intoxication with a molecular size of up to 55 kDa.~The therapy will be performed once no later than 4 hours after the diagnosis of cardiogenic shock.~The duration of hemoadsorption is from 4 to 12 hours. The rate of hemoadsorption is from 80 to 150 ml/min. Anticoagulation is systemic (heparin or sodium citrate)."

Trial Locations (1)

634012

RECRUITING

Tomsk NRMC Cardiology Research Institute, Tomsk

All Listed Sponsors
lead

Efferon JSC

INDUSTRY